维普期刊资源整合服务平台（V6.5）

53篇 您的检索式：作者名="Colonno Rj"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Entecavir resistance is rare in nucleoside na? ve patients with hepatitis B显示文摘	Colonno RJ Rose Batdick CI	2006	Hepatology2006，44，：	1
2	Characterization of antiviral in transgenic mice expressing hepatitis B virus显示文摘	Julander JG Colonno RJ Sidwell RW	2003	Antiviral Res2003，59，3：	1
3	Assessment at three years shows high barrier to resistance is maintained in entecavir treated nueleoside naive patients while resistance emergence in creases over time in lamivudine refractory patients显示文摘	Colonno RJ Rose RE Pokomowski K	2006	Hepatology2006，44，41：	1
4	Long-term entecavir treatment result in sustained antiviral efficacy and prolonged life span in the woodchuck model of chronic hepatitis infection显示文摘	Colonno RJ Genovesi EV Medina I	2001	J Infect Dis2001，184，10：	1
5	In vitro inhibition of hepadnavirus polymcrases by the triphosphates of BMS-200475and lobucavir显示文摘	Hamatake RK Colonno RJ	1998	Antimicrob Agents Chemother1998，42，12：	1
6	Mechanistic characterization and molecular modeling of hepatitis B virus polymerase resistance to entecavir 显示文摘	Walsh AW Langley DR Colonno RJ	2010	PLoS One2010，5，2：	1
7	Emergence ofentecavir resistant hepatitis B virus after one year of therapy in phase Ⅱ&Ⅲ studies is only observed in lamivudine refractory patients显示文摘	Colonno RJ Rose R Levine SM	2004	Hepatology2004，4041，：	1
8	Characteri-zation of antiviral in transgenic mice expressing hepatitis B virus显示文摘	Julander JG Colonno RJ Sidwell RW	2003	Antiviral Res2003，59，3：	1
9	Antigenic conserva- tion and divergence between the viral-specific proteins of poliovir- us type 1 and various picornaviruses显示文摘	Emini EA Schleif WA Colonno RJ	1985	Virology1985，140，1：	1
10	In vitro inhibition of hepadnavirus polymerases by the triphosphates of BMS-200475 and lobucavir显示文摘	Seifer M Hamatake RK Colonno RJ	1998	Antimicrob Agents Chemother1998，42，12：	1
11	In vitro inhibition of hepadnavirus polymerases by the triphosphates of BM8- 200475 and fobueavir显示文摘	Seifer M Hamatake RK Colonno RJ	1998	Antimicrob Agents Chemother1998，42，12：	1
12	Assessment at three years shows high barrier to treated nucleoside nave patients while resistance emergence increases over time in lamivudine refractory patients显示文摘	Colonno RJ Rose RE Pokornowski K	2006	Hepatology2006，44，1：	1
13	Assessment at three years shows high barrier to resistance is maintained in entecavir-treated nuclcoside naive patients while resistance emergence increases over time in lamivudine refractory patients 显示文摘	Colonno RJ Rose RE Pokornowski K	2006	AASLD2006，10，：	1
14	Entecavir resistance is rare in nucleoside naive patients with hepatitis B显示文摘	COLONNO RJ ROSE R BALDICK CJ	2006	Hepatology2006，44，6：	1
15	Assessment at three years shows high barrier to resistance is maintained in entecalvir treated nu- cleoside naive patients while resistance emergence increases over time in lamivudine refractory patients显示文摘	Colonno Rj Rose RE Pokornowski K	2006	Hepat01ogy2006，44，4：	1
16	Four year assessment of ETV resistance in Nucleoside-na ve and lamivudine refractory patients显示文摘	Colonno RJ Rose RE Pokomowski K	2007	J Hepatol2007，46，1：	1
17	Long-term entecavir treatment results in sustained antiviral effiacacy and prolonged life span in thewoodchuckmodel of chronic hepatitis infection 显示文摘	COLONNO RJ GENOVESI EV MEDINA L	2001	Infect Dis2001，184，：	1
18	In vitro inhibition of hepadnavirus polymerases by the triphosphates of BMS-200475 and lobucavir 显示文摘	Seifer M Hamatake RK Colonno RJ	1998	Antimicrob Agents Chemother1998，42，12：	1
19	Evidence for the direct involvement of the rhinovirus canyon in receptor binding显示文摘	Colonno RJ	1988	Proc Nad Acad Sci1988，85，：	1
20	Entecavir resistance is rare in nucleoside naive patients with hepatitis B显示文摘	Colonno RJ Rose R Baldick CJ	2006	Hepatology2006，44，9：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示